LASAACI 2024 Fall Symposium
The Los Angeles Society of Allergy, Asthma and Clinical Immunology (LASAACI) is a CME educational meeting jointly provided by the American College of Allergy, Asthma and Immunology and the LASAACI.
The 2024 program is a four-hour event with Faculty who are experts in their field and will provide evidence-based, clinical topics that address major aspects of attendee’s practices and will provide attendees exposure to new content.
Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of American College of Allergy, Asthma & Immunolgy and California Society of Allergy, Asthma & Immunology (CSAAI). The American College of Allergy, Asthma & Immunolgy is accredited by the ACCME to provide continuing medical education for physicians.
Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 4 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CBRN
The American College of Allergy, Asthma & Immunology (ACAAI) is a provider, approved by the California Board of Registered Nursing, Provider Number CEP17239, for 4 contact hours.
Target Audience
Practicing allergists
Allied health professionals
Learning Objectives
At the conclusion of this Activity learners should be able to…
Updates & Advances in Immunotherapy
1. Recommend opportunities for treatment simplification among existing IT patients, without compromise to clinical outcomes.
2. Chart the clinical benefits of IT using improved strategies for antigen selection and prioritization.
3. Apply tools to engage and retain additional patients on the IT journey.
Allergy and Asthma Prevention
1. Upon completion of this learning activity, participants should be able to appreciate infant microbiota features that distinguish high and low risk for childhood atopy and asthma development
2. Upon completion of this learning activity, participants should be able to define a mechanism by which microbial metabolites promote allergic inflammation
3. Upon completion of this learning activity, participants should be able to recognize that infant gut microbiome manipulation is an intervention currently being tested to prevent childhood allergic sensitization
Mast Cell Disorders
1. Discriminate btween the various forms of mast cell activation disease
2. Summarize key aspects of the diagnosis of mast cell activation disease from clinical suspicion to laboratory studies
3. Review clinical data on treatment options for mast cell disorder
Los Angeles Society of Allergy, Asthma & Clinical Immunology
2024 Fall Symposium
Skirball Cultural Center, Los Angeles CA
Saturday, September 7, 2024
6:30AM-8:20AM Registration, Exhibits & Coffee Break
8:20AM-8:30AM WELCOME AND INTRODUCTION
Sonal Patel, MD, LASAACI President/Program Director
Session Moderator: Sonal Patel, MD
8:30AM-9:30AM The Human Microbiota and Asthma and Allergy
Susan Lynch, PhD
9:30AM-10:30AM Updates and Advances in Immunotherapy
Tricia Sowers, PhD
10:30AM-11:30AM Buffet Brunch, Exhibits, Posters
11:30AM-12:30PM Brought to you by the American College of Allergy, Asthma & Immunology: Transforming Traditional Allergy Care
Tania Elliott, MD, FAAAAI, FACAAI
12:30PM-1:30PM Mast Cell Activation Syndrome: How did we get here?
Katharine M. Woessner, MD, FAAAAI
1:30PM Adjourn
All relevant financial relationships with ineligible companies have been mitigated.
Tania Elliott, MD – Speaker
Consultant: AstraZeneca
Susan Lynch, PhD – Speaker
Advisor: Siolta Therapeutics Inc.; Consultant: Atria Institute, Siolta Therapeutics Inc.; Ownership interest: Siolta Therapeutics Inc.; Royalties or patent beneficiary: Siolta Therapeutics Inc.; Stock/options: Siolta Therapeutics Inc.
Tricia Sowers, PhD – Speaker
Consultant: Accu-Mix, ALK-Abello
Katharine M. Woessner, MD – Speaker
Consultant: AstraZeneca, GSK; Speaker: Amgen, AstraZeneca, GSK, Sanofi, Takeda
Sonal Patel, MD – Planner, Moderator
Advisor: Sanofi; Speaker: Regeneron
Jonathan Corren, MD – Planner
Advisor: AstraZeneca, Regeneron, Sanofi; Independent contractor: Novartis, Regeneron; Researcher: AstraZeneca; Speaker: AstraZeneca, GSK, Novartis, Regeneron, Speaker
Rita Kachru, MD – Planner
Researcher: Aimmune
The following have no relevant financial relationships with ineligible companies to disclose:
Sheila M. Bonilla, MD – Planner
Edward Hu, MD – Planner
Caroline Spagnola, MD – Planner
Andrew K. Wong, MD – Planner
Joseph Yusin, MD – Planner
Karol Anderson – Planner
Available Credit
- 4.00 AMA PRA Category 1 Credit™
- 4.00 Attendance
- 4.00 CBRN